Silphium Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$11.6M |
| 2 |
MYOV
Myovant Sciences Ltd.
MYOV
|
+$7.89M |
| 3 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$7.73M |
| 4 |
ONEM
1Life Healthcare
ONEM
|
+$3.38M |
| 5 |
COUP
Coupa Software Incorporated
COUP
|
+$2.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$13.6M |
| 2 |
NLSN
Nielsen Holdings plc
NLSN
|
+$12.5M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$11M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$6.94M |
| 5 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$6.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.61% |
| 2 | Financials | 16.49% |
| 3 | Technology | 14.6% |
| 4 | Industrials | 9.95% |
| 5 | Energy | 6.24% |
Similar funds
Silphium Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, Silphium Asset Management held 61 positions worth $100M, down 10% from $111M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Silphium Asset Management withdrew a net $18.3M in Q4 2022, closing 21 positions and reducing 5 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $13.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
Against the trend, Silphium Asset Management opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $15.9M.
- Silphium Asset Management's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 140,000 shares worth $15.9M.
- Silphium Asset Management added most to Cowen Inc. Class A Common Stock in Q4 2022, an estimated $7.73M increase.
- Silphium Asset Management's biggest Q4 2022 reduction was Ulta Beauty, cutting an estimated $1.29M.
- Silphium Asset Management fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $13.6M.
- Silphium Asset Management's ten largest holdings make up 65% of its $100M portfolio in Q4 2022.
- Silphium Asset Management opened 19 new positions and closed 21 in Q4 2022.
- Silphium Asset Management's portfolio value fell 10% quarter-over-quarter to $100M.
Based on Silphium Asset Management's 13F filing for Q4 2022, filed 30 Jan 2025.